Complications Associated With Ureteroscopic Management of Upper Tract Urothelial Carcinoma.
BCG Vaccine
/ administration & dosage
Carcinoma, Transitional Cell
/ therapy
Chemotherapy, Adjuvant
/ adverse effects
Fever
/ epidemiology
Humans
Incidence
Kidney Neoplasms
/ therapy
Mitomycin
/ administration & dosage
Postoperative Complications
/ epidemiology
Prospective Studies
Retrospective Studies
Treatment Outcome
Ureteral Neoplasms
/ therapy
Ureteral Obstruction
/ epidemiology
Ureteroscopy
/ adverse effects
Urinary Tract Infections
/ epidemiology
Journal
Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
02
07
2020
revised:
07
09
2020
accepted:
17
09
2020
pubmed:
9
10
2020
medline:
4
2
2022
entrez:
8
10
2020
Statut:
ppublish
Résumé
To compile and examine safety data from clinical studies of endoscopic management of patients with low-grade upper tract urothelial carcinoma (UTUC) to identify rates and factors associated with reported complications. Ovid Medline and Ovid Medline Daily (with Embase as secondary search) including citations from 1946-2018 were queried using the following terms: ureteroscopy, ureter, catheter, endoscopy, complication, adverse events, morbidity, ablation, laser, upper tract urothelial carcinoma, ureteral stricture, ureteral stenosis, and ureteral injury. Abstracts were reviewed for relevance; diagnostic studies, case studies, and reviews were excluded. Thirty-eight publications (7 prospective, 31 retrospective) representing >1100 patients were identified. Ureteral stricture was the most frequently reported complication (studies; rates) (26/38; 0-27%), with incidence associated with number of procedures and treatment method. Bleeding, infection, and fever were most common with adjuvant treatment (BCG or mitomycin). Serious and fatal complications were rare. Ureteral stricture is the most frequent complication of endoscopic UTUC management but can be managed successfully in most cases. Most complications were minor. Although additional prospective studies are needed, these results support the safety of ureteroscopic management of UTUC in appropriately selected patients.
Identifiants
pubmed: 33031842
pii: S0090-4295(20)31234-6
doi: 10.1016/j.urology.2020.09.036
pii:
doi:
Substances chimiques
BCG Vaccine
0
Mitomycin
50SG953SK6
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
87-95Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.